4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-25-021050
CEO and President bought 675,675 shares at $0.37 ($250,000)
- CEO and President gave up 3,104 shares (to pay taxes)
- CEO and President acquired 12,740 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KLEMP WALTER V · CEO and President
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-20 | Exercise or conversion : show line 1 in the form | +3,750 | 62,046 | D | ||
| 2025-06-20 | Shares withheld for taxes : show line 2 in the form | −914 | $0.27 | $244 | 61,132 | D |
| 2025-06-22 | Exercise or conversion : show line 3 in the form | +8,990 | 70,122 | D | ||
| 2025-06-22 | Shares withheld for taxes : show line 4 in the form | −2,190 | $0.27 | $585 | 67,932 | D |
| 2025-06-23 | Purchase : show line 5 in the form | +675,675 | $0.37 | $250,000 | 743,607 | D |
| Open-market purchases · 675,675 sh · avg $0.37 · $250,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-20 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −3,750 | 391,446 | D |
| 2025-06-22 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −8,990 | 382,456 | D |
| 2025-06-23 | Purchase : show line 8 in the form Series E Warrants | −2,027,025 | 2,409,481 | D |
Loading xslF345X05/rdgdoc.xml…